| | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C26H18FNO2 |
| Molar mass | 395.433 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
FDU-PB-22 is a derivative of JWH-018 that is presumed to be a potent agonist of the CB1 receptor, and has been sold online as a designer drug. [1] [2]
FDU-PB-22 acts as a full agonist with a binding affinity of 1.19nM at CB1 and 2.43nM at CB2 cannabinoid receptors. [3]
FDU-PB-22 is a controlled substance in Germany and is banned in Japan and Sweden. [4]